Maxime Dely – Simple Transfusion or Red Cell Exchange: Two Techniques, Two Philosophies of Care
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, posted on LinkedIn:
”Simple transfusion or red cell exchange: two techniques, two philosophies of care.
When we think of a blood transfusion, we usually imagine a straightforward act – giving red blood cells to correct anemia or improve oxygenation.
But in certain cases – sickle cell disease, polycythemia vera, severe malaria, or intoxications – there’s another option: red cell exchange by apheresis.
Instead of adding more blood, we gradually replace the patient’s red cells with healthy donor cells using an apheresis machine.
The total blood volume remains constant, and the process is precise, controlled, and personalized for each patient.
The benefits are clear:
- Rapid correction of abnormal red cell proportions.
- No iron overload – a common issue with repeated transfusions.
- Improved blood viscosity, reducing vaso-occlusive risks.
- Above all, a tailored, patient-specific approach – precision transfusion medicine.
Of course, this technique requires specialized expertise, equipment, and teamwork. But it represents where medicine is heading: more targeted, safer, and more human.
Behind every red cell exchange stands a dedicated team – nurses, physicians, and biologists – turning advanced technology into meaningful care.”

Keep up with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis